Identifying disparities in germline and somatic testing for ovarian cancer-Reference-Cited by-同舟云学术

Identifying disparities in germline and somatic testing for ovarian cancer

Published:2019-05 Issue:2 Volume:153 Page:297-303
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Huang Marilyn,Kamath Priyanka,Schlumbrecht Matthew^ORCID,Miao Feng,Driscoll Devin,Oldak Sean^ORCID,Slomovitz Brian,Koru-Sengul Tulay^ORCID,George Sophia

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2018. CA Cancer J Clin 68:7–30, 2018.

2. Society AC: Cancer Facts & Figures 2018 - Special Section: Ovarian Cancer. ACS, 2018.

3. Norquist BM, Harrell MI, Brady MF, et al.: Inherited Mutations in Women With Ovarian Carcinoma. JAMA Oncol 2:482–90, 2016.

4. Swisher EM, Norquist BM, Pennington KP, et al..: DNA repair mutations and outcomes in ovarian cance—response. Clin Cancer Res 21:659, 2015.

5. 2.2019) NGFH-RABaOV: Available from: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf July 30, 2018.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over;Gynecologic Oncology;2024-08

2. Racial and ethnic disparities in reproductive medicine in the United States: a narrative review of contemporary high-quality evidence;American Journal of Obstetrics and Gynecology;2024-07

3. Social determinants of health and use of neoadjuvant chemotherapy and germline genetic testing in patients with early stage triple negative breast cancer (TNBC) in the community oncology setting;2024-06-06

4. No Racial Disparities Observed Using Point-of-Care Genetic Counseling and Testing for Endometrial and Ovarian Cancer in a Diverse Patient Population: A Retrospective Cohort Study;Cancers;2024-04-22

5. Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake;Gynecologic Oncology;2024-04